Volta Labs
PrivateLast Round
Series A
Extension
Mar 22, 2024
Est. Valuation
$92.7M
Total Funding Raised
$37.7M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Volta Labs operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Series A Extension round in March 2024.
Volta Labs is a biotechnology company that provides a biological automation and genomic sample preparation platform designed to streamline complex workflows in genomics research through innovative automation and miniaturization techniques.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Workflow Automation
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Volta Labs Comparables
Compare Volta Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CyteSi, Inc. | 83% | |
| INTEGRA Holding AG | 83% | |
| Danaher | 78% |
For institutional investors. Book with your work email.
Volta Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 22, 2024 | ||||
| Seed Round | Dec 29, 2023 | ||||
| Series A | Mar 17, 2022 | ||||
| Seed | Mar 18, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Volta Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Blindspot Ventures | Series A |
| Maverick Ventures | Series A, Seed |
| Fundomo | Series A Extension |
| Khosla Ventures | Series A |
| Blindspot Ventures | Series A |
| Y Combinator | Seed |
| Casdin Capital | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 78% MoM.
- Aug 12, 2026
Callisto identified as flagship genomics product.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesNov 12, 2026
Volta Labs, Inc. launches the AXELIOS 1 Library Prep App using SBX-D chemistry on the Callisto(TM) Sample Prep System in collaboration with Roche Diagnostics in Washington on Nov 12th '26.
For institutional investors. Book with your work email.
Volta Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Volta Labs's valuation, stock price, and market status.
Is Volta Labs a public or private company?
Volta Labs is a private company.
What is the current stock price of Volta Labs?
Volta Labs is a private company, so its shares have no public market price. Caplight tracks Volta Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Volta Labs worth (valuation)?
Volta Labs's valuation is estimated at $92.7M based on funding round data.
Can I buy Volta Labs stock?
Volta Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Volta Labs's last funding round?
Volta Labs's most recent funding round was Series A Extension on March 22, 2024.
Who are the main investors in Volta Labs?
Key investors in Volta Labs include Maverick Ventures.
Will Volta Labs IPO soon?
No public IPO plans have been announced for Volta Labs.
How can I track Volta Labs secondary market activity?
Caplight tracks bids, offers, and trades in Volta Labs's shares on secondary markets.